Sign up to access all valuation multiples
Clinica Las Condes SA provides clinical medical services specializing in emergency, diagnostic, clinical support, and medical consultation services. It provides medical and surgical hospitalization, transplant units, units of intensive and intermediate care; for adults, pediatric and neonatology, pavilionssurgical, post-operative recovery, radiology, and other related services. The company along with its subsidiaries, operates in the following segments; Hospitalization, Outpatient, Insurance, and Others. A majority of its revenue is derived from the Hospitalization segment which corresponds to services provided to patients who are hospitalized and occupy bed space.
1979
3.1K+
Last FY Revenue $179M
Last FY EBITDA -$67.9M
$421M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Clinica Las Condes reported revenue of $179M and EBITDA of -$67.9M.
Clinica Las Condes expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clinica Las Condes valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $179M | XXX | XXX | XXX |
| Gross Profit | XXX | $27.6M | XXX | XXX | XXX |
| Gross Margin | XXX | 15% | XXX | XXX | XXX |
| EBITDA | XXX | -$67.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -38% | XXX | XXX | XXX |
| EBIT | XXX | -$60.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | -34% | XXX | XXX | XXX |
| Net Profit | XXX | -$81.8M | XXX | XXX | XXX |
| Net Margin | XXX | -46% | XXX | XXX | XXX |
| Net Debt | XXX | $189M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Clinica Las Condes has current market cap of CLP 234B (or $244M), and EV of CLP 404B (or $421M).
As of October 2, 2025, Clinica Las Condes's stock price is CLP 15997 (or $17).
See Clinica Las Condes trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $421M | $244M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialClinica Las Condes's trades at 2.3x EV/Revenue multiple, and -6.2x EV/EBITDA.
See valuation multiples for Clinica Las Condes and 15K+ public compsAs of October 2, 2025, Clinica Las Condes has market cap of $244M and EV of $421M.
Equity research analysts estimate Clinica Las Condes's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clinica Las Condes's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $244M | XXX | $244M | XXX | XXX | XXX |
| EV (current) | $421M | XXX | $421M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.2x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -7.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -3.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -182.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClinica Las Condes's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $29K for the same period.
Clinica Las Condes's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clinica Las Condes's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clinica Las Condes and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -38% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $29K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Monash IVF Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Pacific Smiles Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clinica Las Condes acquired XXX companies to date.
Last acquisition by Clinica Las Condes was XXXXXXXX, XXXXX XXXXX XXXXXX . Clinica Las Condes acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Clinica Las Condes founded? | Clinica Las Condes was founded in 1979. |
| Where is Clinica Las Condes headquartered? | Clinica Las Condes is headquartered in Chile. |
| How many employees does Clinica Las Condes have? | As of today, Clinica Las Condes has 3.1K+ employees. |
| Is Clinica Las Condes publicy listed? | Yes, Clinica Las Condes is a public company listed on SGO. |
| What is the stock symbol of Clinica Las Condes? | Clinica Las Condes trades under LAS CONDES ticker. |
| When did Clinica Las Condes go public? | Clinica Las Condes went public in 1992. |
| Who are competitors of Clinica Las Condes? | Similar companies to Clinica Las Condes include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Monash IVF Group. |
| What is the current market cap of Clinica Las Condes? | Clinica Las Condes's current market cap is $244M |
| Is Clinica Las Condes profitable? | Yes, Clinica Las Condes is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
